FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

José Luis Calleja

Research Profile

Living Beings

Hepacivirus

Chemicals & Drugs

Disorders

Procedures

Co-author Network

Publications

TOP 3
José Luis Calleja; Beatriz Peñas
[Entecavir].
Antonio Olveira; C Serrano; José Carlos Erdozain; José Luis Calleja; Pilar Castillo; JM Segura; Pedro Escartín
[Interferon, ribavirin and amantadine in prior nonresponders to interferon and ribavirin therapy with chronic hepatitis C (genotype 1)].
Fatima Esquivel; Agustín Albillos; Flavio Carrión; Alfredo Prieto; Eduardo Reyes; Belén Martínez-Martin; José Luis Calleja; Guillermo Cacho; Melchor Alvarez-Mon
Relationship between response to interferon-alpha and function of peripheral blood mononuclear cells in chronic hepatitis C patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of José Luis Calleja (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: José Luis Calleja; Beatriz Peñas
[Entecavir].
Enfermedades infecciosas y microbiología clínica 2008;26 Suppl 7():39-48.
2003: Antonio Olveira; C Serrano; José Carlos Erdozain; José Luis Calleja; Pilar Castillo; JM Segura; Pedro Escartín
[Interferon, ribavirin and amantadine in prior nonresponders to interferon and ribavirin therapy with chronic hepatitis C (genotype 1)].
Gastroenterología y hepatología 2003;26(8):465-8.
2002: Fatima Esquivel; Agustín Albillos; Flavio Carrión; Alfredo Prieto; Eduardo Reyes; Belén Martínez-Martin; José Luis Calleja; Guillermo Cacho; Melchor Alvarez-Mon
Relationship between response to interferon-alpha and function of peripheral blood mononuclear cells in chronic hepatitis C patients.
Digestive diseases and sciences 2002;47(10):2154-62.
2001: José Luis Calleja; Agustín Albillos; I Rossi; R Moreno; F Domper; J L Martínez; Pedro Escartín
Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response.
Alimentary pharmacology & therapeutics 2001;15(2):241-9.
1999: José Luis Calleja; Agustín Albillos; Ricardo Moreno-Otero; I Rossi; Guillermo Cacho; F Domper; M Yebra; Pedro Escartín
Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
Alimentary pharmacology & therapeutics 1999;13(9):1179-86.
1998: Agustín Albillos; Juan Carlos García-Pagán; J Iborra; JC Bandi; Guillermo Cacho; M Pérez-Paramo; Angels Escorsell; José Luis Calleja; Pedro Escartín; Jaime Bosch
Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
Gastroenterology 1998;115(1):116-23.
1998: Agustín Albillos; Guillermo Cacho; C Barrios; Melchor Alvarez-Mon; I Rossi; J Gómez-Arnau; M Pérez-Páramo; José Luis Calleja; J Muñoz; M T Torres; R Daza; valentin Cuervas-Mons; Pedro Escartín
Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin A-induced hypertension.
Hepatology (Baltimore, Md.) 1998;27(2):332-8.
1997: Agustín Albillos; M Perez-Paramo; Guillermo Cacho; J Iborra; José Luis Calleja; I Millán; J Muñoz; I Rossi; Pedro Escartín
Accuracy of portal and forearm blood flow measurements in the assessment of the portal pressure response to propranolol.
Journal of hepatology 1997;27(3):496-504.
1997: M Pérez-Paramo; Agustín Albillos; José Luis Calleja; C Salas; M C Marín; M L Marcos; Guillermo Cacho; Pedro Escartín; J Ortiz Berrocal
Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
Digestive diseases and sciences 1997;42(8):1734-40.
1997: José Luis Calleja; Luis E Abreu; Agustín Albillos; Guillermo Cacho; A Garrido; Pedro Escartín
[Endoscopic ultrasonography: current and future perspectives].
Gastroenterología y hepatología 1997;20(3):141-50.
1996: Guillermo Cacho; L Abreu; José Luis Calleja; E Prados; A Albillos; C Chantar; J L Perez Picouto; Pedro Escartín
Arterioportal fistula and hemobilia with associated acute cholecystitis: a complication of percutaneous liver biopsy.
Hepato-gastroenterology 1996;43(10):1020-3.
1996: José Luis Calleja; A Albillos; Guillermo Cacho; J Iborra; L Abreu; Pedro Escartín
Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
Journal of hepatology 1996;24(3):308-12.
1994: A Albillos; J L Lledó; Rafael Bañares; I Rossi; J Iborra; José Luis Calleja; A Garrido; P Escartin; Jaime Bosch
Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
Hepatology (Baltimore, Md.) 1994;20(3):611-7.
1994: A Albillos; I Rossi; J Iborra; J L Lledó; José Luis Calleja; C Barrios; P García; Pedro Escartín
Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.
Journal of hepatology 1994;21(1):88-94.
1992: J L Patier; José Luis Calleja; J A Lorente; R de Pablo
[Shock with 2 concomitant causes: sudden onset of autoimmune polyglandular syndrome type II].
Revista clínica española 1992;191(2):113-4.
1992: J L Patier; C J Martínez; José Luis Calleja; F Mampaso
[An idiopathic segmental infarct of the greater omentum: a new case with massive hemoperitoneum].
Revista clínica española 1992;190(8):430-1.
1990: Carlos Montalban; José Luis Calleja; A Erice; Fernando Laguna; B Clotet; D Podzamczer; J Cobo; J Mallolas; M Yebra; A Gallego
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.
The Journal of infection 1990;21(3):261-70.
1990: F Ruiz-Palomo; José Luis Calleja; L Fogue
Primary liposarcoma of the lung in a young woman.
Thorax 1990;45(4):298-9.
1990: Carlos Montalbán; S Arechaga; José Luis Calleja; Carmen Bellas; J L Patier; A Berenguer; A García Villanueva; J Marcos Robles
[Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy].
Medicina clínica 1990;94(12):461-4.
1990: Carlos Montalbán; José Luis Calleja
[Visceral leishmaniasis: a new opportunistic infection in carriers of the human immunodeficiency virus].
Medicina clínica 1990;94(5):176-9.
1990: Carlos Montalban; José Luis Calleja
Leishmaniasis masking tuberculosis.
Lancet 1990;335(8684):299-300.
1989: Carlos Montalbán; J L Patier; José Luis Calleja; J Perales; M Serrano; Carmen Bellas
[Neutropenic enterocolitis during treatment of lymphoproliferative neoplasms].
Medicina clínica 1989;93(17):649-52.
1989: Carlos Montalbán; José Luis Calleja; Carmen Bellas; A Erice; J L Patier; I Sánchez-Vegazo; J L Salvador
[Lymphoma of the rectum associated with lymphoid nodular hyperplasia in a common variable immunodeficiency].
Medicina clínica 1989;93(10):377-9.
1989: Carlos Montalban; R Martinez-Fernandez; José Luis Calleja; Juan de Dios García Díaz; R Rubio; F Dronda; S Moreno; M Yebra; C Barros; J Cobo
Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.
Reviews of infectious diseases 1989;11(4):655-60.